Orchid Pharma signs licensing, supply pact with Russia's Pharmasyntez for Exblifep
Published on: July 7, 2026, 10:49 p.m. | Source: CNBC TV18
Orchid Pharma has entered into a licensing and supply agreement with Russia's Pharmasyntez JSC to commercialise Exblifep (cefepime/enmetazobactam) in Russia, subject to approval from the country's Ministry of Health. The antibiotic is approved by the US FDA and the European Medicines Agency.
